RT @arvindcanchi: Ixekizumab and brodalumab provide the most rapid response and earliest clinical benefit in Rx of Psoriasis at week 2 amon…
RT @arvindcanchi: Ixekizumab and brodalumab provide the most rapid response and earliest clinical benefit in Rx of Psoriasis at week 2 amon…
Ixekizumab and brodalumab provide the most rapid response and earliest clinical benefit in Rx of Psoriasis at week 2 among the biologics. Have a renal TX pt with Psoriasis. No data in that group I guess @silvishah @raja_1980 @BhushanSree @SreejithDr https
RT @DermatolTher: Biologic therapies have transformed the treatment of moderate-to-severe #psoriasis and have markedly improved multiple #p…
Biologic therapies have transformed the treatment of moderate-to-severe #psoriasis and have markedly improved multiple #patient outcomes. This article: https://t.co/TYZhQldwYx investigates the rapid response of biologic treatments for moderate-to severe pl